- Amanat N, McDonald M, Godfrey C, Bilston L, Little D. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. J Bone Miner Res 2007; 22(6): 867–76.
- Andreshak J L, Rabin S I, Patwardhan A G, Wezeman F H. Tibial segmental defect repair: chondrogenesis and biomechanical strength modulated by basic fibroblast growth factor. Anat Rec 1997; 248(2): 198–204.
- Bae Y H, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Rel 2011; 153(3): 198–205.
- Bernhardsson M, Sandberg O, Ressner M, Koziorowski J, Malmquist J, Aspenberg P. Shining dead bone: cause for cautious interpretation of [(18)F]NaF PET scans. Acta Orthop 2018; 89(1): 124–7.
- de Klerk J M, van Dijk A, van het Schip A D, Zonnenberg B A, van Rijk P P. Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases. J Nucl Med 1992; 33(5): 646–51.
- Kirpotin D B, Drummond D C, Shao Y, Shalaby M R, Hong K, Nielsen U B, Marks J D, Benz C C, Park J W. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 2006; 66(13): 6732–40.
- Kohane D S, Tse J Y, Yeo Y, Padera R, Shubina M, Langer R. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J Biomed Mater Res Part A 2006; 77(2): 351–61.
- Lewington V J. Bone-seeking radionuclides for therapy. J Nucl Med 2005; 46 (Suppl. 1): 8s–47s.
- Mathavan N, Koopman J, Raina D B, Turkiewicz A, Tägil M, Isaksson H. 18F-fluoride as a prognostic indicator of bone regeneration. Acta Biomater 2019; 90: 403–11.
- Palma E, Correia J D G, Campello M P C, Santos I. Bisphosphonates as radionuclide carriers for imaging or systemic therapy. Mol BioSystems 2011; 7(11): 2950–66.
- Perrin D D. Binding of tetracyclines to bone. Nature 1965; 208(5012): 787–8.
- Raina D B, Isaksson H, Hettwer W, Kumar A, Lidgren L, Tägil M. A biphasic calcium sulphate/hydroxyapatite carrier containing bone morphogenic protein-2 and zoledronic acid generates bone. Sci Rep 2016; 6: 26033.
- Raina D B, Larsson D, Sezgin E A, Isaksson H, Tägil M, Lidgren L. Biomodulation of an implant for enhanced bone–implant anchorage. Acta Biomater 2019; 96:619–30.
- Ramanlal Chaudhari K, Kumar A, Megraj Khandelwal V K, Ukawala M, Manjappa A S, Mishra A K, Monkkonen J, Ramachandra Murthy R S. Bone metastasis targeting: a novel approach to reach bone using zoledronate anchored PLGA nanoparticle as carrier system loaded with docetaxel. J Control Rel 2012; 158(3): 470–8.
- Yuan Y, Liu C, Qian J, Wang J, Zhang Y. Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials 2010; 31(4): 730–40.
- Zhao H, Wu C, Gao D, Chen S, Zhu Y, Sun J, Luo H, Yu K, Fan H, Zhang X. Antitumor effect by hydroxyapatite nanospheres: activation of mitochondria-dependent apoptosis and negative regulation of phosphatidylinositol-3-kinase/protein kinase B pathway. ACS Nano 2018; 12(8): 7838–54.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research